Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population

Documenti analoghi

• Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
  di: Wang, Sidi, et al.
  Pubblicazione: (2026)
• A robust score test in g-computation for covariate adjustment in randomized clinical trials leveraging different variance estimators via influence functions
  di: Zhang, Xin, et al.
  Pubblicazione: (2025)
• Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
  di: Maity, Arnab Kumar, et al.
  Pubblicazione: (2024)
• On regional treatment effect assessment using robust MAP priors
  di: Zhang, Xin, et al.
  Pubblicazione: (2026)
• Toward Valid Generative Clinical Trial Data with Survival Endpoints
  di: Chassat, Perrine, et al.
  Pubblicazione: (2025)